Skip to main content
. 2019 Nov 27;47(3):695–712. doi: 10.1007/s00259-019-04583-2

Table 2.

Dosimetric calculations of 177Lu-PSMA-617 therapy compared to SUVmax values

Skeletal metastases Lymph node metastases Visceral metastases
Absorbed dose SUVmax Absorbed dose SUVmax Absorbed dose SUVmax
Patient Therapy cycles Accumulated activity (GBq) D/Aa(Gy/GBq) Dtotb(Gy) Baseline After 2 cycles After 3/4 cycles D/A1(Gy/GBq) Dtot2 (Gy) Baseline After 2 cycles After 3/4 cycles D/A1(Gy/GBq) Dtot2 (Gy) Baseline After 2 cycles After 3/4 cycles
1 3 17.7 1.70 30.16 12.40 9.10 7.20 np np 16.50 3.33 7.93 / / / / /
2 3 19.3 3.68 71.17 21.53 8.40 / / / / / / / / / / /
3 3 18.6 3.12 58.13 18.12 11.00 11.97 np np 20.88 4.60 2.95 / / / / /
4 3 16.3 2.30 37.49 8.00 5.40 5.49 / / / / / / / / / /
5 3 17.9 5.90 105.49 15.00 6.40 8.70 / / 4.10 1.20 1.10 / / / / /
6 3 18.1 1.70 30.80 30.37 28.87 22.07 2.85 51.64 16.00 21.80 22.50 1.70 30.80 28.55 34.25 24.70
7 3 18.8 7.50 141.23 27.65 18.83 14.10 / / / / / 3.25 61.20 16.90 12.20 14.60
8 2 12.7 4.95 62.87 9.99 12.79 / / / / / / / / / / /
9 3 18.6 1.10 20.45 28.93 15.63 / / / / / / 2.35 43.69 24.10 17.75 /
10 4 + 2 24.3 2.80 68.04 18.99 13.32 9.21 2.25 54.68 21.43 12.48 np / / / / /
11 4 + 2 25.6 4.19 107.31 7.10 15.10 10.30 3.60 92.20 66.40 4.80 8.80 / / / / /
12 2 12.8 1.39 17.78 15.00 7.10 / 1.72 22.00 16.70 8.00 / / / / / /
13 4 25.3 3.40 86.09 22.10 / 12.50 6.20 156.98 66.30 / 29.30 4.30 108.88 37.90 / 15.40
14 4 24.9 / / / / / 1.90 47.31 18.20 / / np np 2.50 / /
15 3 18.3 / / 11.20 21.40 6.80 2.08 38.04 10.20 28.70 19.60 / / / / /
16 4 23.3 4.00 93.36 31.00 / / / / / / / / / / / /
17 4 24.9 / / / / / 4.00 99.60 65.20 / 16.10 / / / / /
18 3 18.1 / / / / / / / / / / 3.60 65.16 19.30 / 14.00
19 4 24.4 13.00 317.20 37.50 / 4.80 / / / / / 5.00 122.00 14.15 12.20 10.85
20 4 + 2 37.13 / / / / / 3.00 111.39 21.60 / 8.60 / / / / /
21 2 10.8 6.40 68.86 22.40 20.10 / 8.70 93.61 106.60 61.40 / / / / / /
22 4 23.8 / / / / / 2.90 69.02 39.80 5.40 3.20 / / / / /
23 4 24.6 2.37 58.30 57.27 / 16.30 / / / / / 2.80 68.88 22.66 / 17.31
24 4 25.3 6.00 151.62 5.00 / 3.40 2.00 50.60 10.00 / 7.80 / / / / /
25 4 24.4 6.66 162.37 36.40 / / / / 37.80 / / / / / / /
26 4 25.3 3.72 94.26 29.20 / 2.20 np np 15.90 / 3.30 np np 17.30 / 11.80
27 3 19.0 / / / / / 0.70 13.30 15.90 / / 0.76 14.44 16.50 / /
28 4 + 1 25.0 3.70 92.50 15.70 / 12.00 np np 10.13 / 5.57 np np / / /
29 3 16.0 / / / / / 1.80 28.87 18.90 / 24.20 / / / / /
30 4 25.5 3.20 81.60 12.79 / 3.35 np np 9.25 / 1.21 / / / / /
31 4 23.7 1.25 18.96 41.06 / 7.70 6.30 149.31 44.15 / 14.54 / / / / /
32 4 21.5 2.10 45.15 26.95 / 10.16 / / / / / / / / / /
Mean 21.3 4.01 89.31 22.47 13.82 9.80 3.12 66.37 29.93 15.17 11.50 2.97 64.38 19.99 19.10 15.52
SD 5.2 2.64 66.26 12.36 6.71 5.26 2.07 39.92 26.36 18.48 9.12 1.38 36.61 9.35 10.43 4.59
Minimum 10.8 1.10 17.78 5.00 5.40 2.20 0.70 13.30 4.10 1.20 1.10 0.76 14.44 2.50 12.20 10.85
Maximum 37.1 13.00 317.20 57.27 28.87 22.07 8.70 156.98 106.60 61.40 29.30 5.00 122.00 37.90 34.25 24.70
aabsorbed dose per unit administered activity Max/min 3.5 11.82 17.84 11.45 5.35 10.03 12.43 11.80 26.00 51.17 26.64 6.58 8.45 15.16 2.81 2.28

btotal cumulative dose

np = not possible to calculate

/ = not performed